Massachusetts based Trax Surgical, LLC, an orthopedic product development and distribution company focused on advancing solutions for the extremities market, announced today that it has performed its first case using its REDIFIX implant. The system was recently used as part of a mid-foot reconstruction. Surgeons noted that the placement, reduction, and fixation were easy to perform and offered excellent control.
Shane Shankle, CEO of Trax Surgical said, "In a short time, we've built a catalog of widely used extremity products. The REDIFIX system offers meaningful advantages, and we believe it will become a standard tool in orthopedics."
Trax Surgical received its FDA 510(k) clearance to market the REDIFIX Suture Anchor System in late April of this year. The REDIFIX system features a cannulated, threaded distal implant connected to a proximal implant by a loop of high‑strength suture and a unique sliding knot. Delivery is straightforward: a guidewire is placed, a pilot hole is drilled, and the implant is advanced into position over the wire. The proximal implant and target tissues are then reduced by applying traction to the trailing suture.
"We believe this system can support a broad range of orthopedic procedures and look forward to partnering with surgeons to bring those applications to life." said Steven Ek, Director of R&D.
